ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

YS YS Biopharma Company Ltd

0.9779
0.0278 (2.93%)
시간외 거래
최종 업데이트: 06:37:05
15분 지연
기업명 주식 심볼 시장 주식 타입
YS Biopharma Company Ltd YS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0278 2.93% 0.9779 06:37:05
개장가 저가 고가 종가 전일 종가
1.03 0.95 1.03 0.9779 0.950101
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202405:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
29/04/202421:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
19/04/202420:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
18/04/202421:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
16/04/202421:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
09/04/202421:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
03/04/202421:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
05/03/202422:00PRNUSYS Biopharma Announces Board Changes and Strategic..
23/02/202407:00PRNUSYS Biopharma Announces Results of Extraordinary General..
18/02/202418:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
17/02/202410:20PRNUSYS Biopharma Announces Results of Extraordinary General..
14/02/202422:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
14/02/202421:50PRNUSYS Biopharma Announces Appointment of New Directors
12/02/202422:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
09/02/202420:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
09/02/202408:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
23/01/202407:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
08/01/202422:00PRNUSYS Biopharma Announces Changes to its Board Committees
21/12/202306:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
20/12/202322:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
14/11/202322:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
31/10/202321:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
26/10/202321:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
26/09/202321:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
15/09/202321:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
05/09/202321:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
25/08/202305:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
16/08/202306:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
27/07/202306:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
22/07/202305:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..
01/06/202321:30PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..
18/05/202321:25PRNUSYS Biopharma to Participate in the Virtual Benchmark..